Drug Profile
Research programme: dimebolin analogues - ChemDiv
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ChemDiv
- Class Antidementias; Indoles; Small molecules
- Mechanism of Action Cholinesterase inhibitors; G protein-coupled receptor modulators; NMDA receptor antagonists; Serotonin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease; Cognition disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cognition-disorders in USA
- 04 Sep 2008 Preclinical trials in Cognition disorders in USA (unspecified route)